𝔖 Scriptorium
✦   LIBER   ✦
πŸ“

Target Validation in Drug Discovery

✍ Scribed by Brian W. Metcalf, Susan Dillon

Publisher
Academic Press
Year
2006
Tongue
English
Leaves
23
Edition
1
Category
Library
⬇  Acquire This Volume

No coin nor oath required. For personal study only.

✦ Synopsis

The sequencing of the human genome has offered a genetic description of the entire repertoire of human genes, including a subset of disease targets. Despite this knowledge, now publically available, clinical pipelines are not yet enriched in drugs derived from targets emanating from this massive sequencing effort. A major concern for researchers in the biotechnology and pharmaceutical industries is how to choose the most likely targets for drug discovery and how to validate them.Target Validation in Drug Discovery describes the background for the choice of target for several successful biological drugs (protein therapeutics). It offers excellent analyses of the underlying biology, the establishment of relative assays, and the translation to clinical trials of these drugs. Professionals in biotechnology and pharmaceutical drug discovery, clinical development, students, and academics in related areas of study will find this a unique reference for years to come.

πŸ“œ SIMILAR VOLUMES

Target Validation in Drug Discovery
πŸ“ Target Validation in Drug Discovery
✍ Brian W. Metcalf, Susan Dillon πŸ“‚ Library πŸ“… 2006 πŸ› Academic Press 🌐 English

This work presents a comprehensive contemporary framework for approaching target validation in drug discovery. It begins with a detailed description of new enabling technologies, including aptamers, RNA interference, functional genomics, and proteomics. The next section looks at biologic drug deve

Target Identification and Validation in
πŸ“ Target Identification and Validation in Drug Discovery: Methods and Protocols
✍ Marta CortΓ©s-Cros, Tobias Schmelzle, Volker M. Stucke, Francesco Hofmann (auth.) πŸ“‚ Library πŸ“… 2013 πŸ› Humana Press 🌐 English

<p><p>The major reason for the elevated costs of drug development in the pharmaceutical industry is the high attrition rate. In <i>Target Identification and Validation in Drug Discovery: Methods and Protocols</i>, expert researchers in the field detail many of the methods which are now commonly used

Target Identification and Validation in
πŸ“ Target Identification and Validation in Drug Discovery: Methods and Protocols
✍ JΓΌrgen Moll, Sebastian Carotta πŸ“‚ Library πŸ“… 2019 πŸ› Springer New York; Humana 🌐 English

<p>This second edition book explores breakthrough technologies in the field of drug target identification and validation. The volume emphasizes particularly revolutionary technologies, such as CRISPR-related screening, β€œbig data,” and <i>in silico</i> approaches, as well as <i>in vivo</i> applicatio

Target Identification and Validation in
πŸ“ Target Identification and Validation in Drug Discovery: Methods and Protocols
✍ Marta CortΓ©s-Cros, Tobias Schmelzle, Volker M. Stucke, Francesco Hofmann (auth.) πŸ“‚ Library πŸ“… 2013 πŸ› Humana Press 🌐 English

<p><p>The major reason for the elevated costs of drug development in the pharmaceutical industry is the high attrition rate. In <i>Target Identification and Validation in Drug Discovery: Methods and Protocols</i>, expert researchers in the field detail many of the methods which are now commonly used